LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4

Metabolism. 2021 May:118:154727. doi: 10.1016/j.metabol.2021.154727. Epub 2021 Feb 11.

Abstract

Background: Metabolic syndrome (MetS) is characterized by a cluster of interconnected risk factors -hyperglycemia, dyslipidemia, hypertension and obesity- leading to an increased risk of cardiovascular events. Small extracellular vesicles (sEVs) can be considered as new biomarkers of different pathologies, and they are involved in intercellular communication. Here, we hypothesize that sEVs are implicated in MetS-associated endothelial dysfunction.

Methods: Circulating sEVs of non-MetS (nMetS) subjects and MetS patients were isolated from plasma and characterized. Thereafter, sEV effects on endothelial function were analyzed by measuring nitric oxide (NO) and reactive oxygen species (ROS) production, and mitochondrial dynamic proteins on human endothelial aortic cells (HAoECs).

Results: Circulating levels of sEVs positively correlated with anthropometric and biochemical parameters including visceral obesity, glycaemia, insulinemia, and dyslipidemia. Treatment of HAoECs with sEVs from MetS patients decreased NO production through the inhibition of the endothelial NO-synthase activity. Injection of MetS-sEVs into mice impaired endothelium-dependent relaxation induced by acetylcholine. Furthermore, MetS-sEVs increased DHE and MitoSox-associated fluorescence in HAoECs, reflecting enhanced cytosolic and mitochondrial ROS production which was not associated with mitochondrial biogenesis or dynamic changes. MetS patients displayed elevated circulating levels of LPS in plasma, and, at least in part, it was associated to circulating sEVs. Pharmacological inhibition and down-regulation of TLR4, as well as sEV-carried LPS neutralization, results in a substantial decrease of ROS production induced by MetS-sEVs.

Conclusion: These results evidence sEVs from MetS patients as potential new biomarkers for this syndrome, and TLR4 pathway activation by sEVs provides a link between the endothelial dysfunction and metabolic disturbances described in MetS.

Keywords: Endothelial dysfunction; Exosomes; Insulin resistance; Metabolic syndrome; TLR4/LPS axis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cohort Studies
  • Cytosol / metabolism
  • Endothelium, Vascular / pathology*
  • Extracellular Vesicles / metabolism*
  • Female
  • Humans
  • Lipopolysaccharides / metabolism*
  • Male
  • Metabolic Syndrome / metabolism*
  • Mice
  • Middle Aged
  • Mitochondria / metabolism
  • Nitric Oxide / metabolism
  • Organelle Biogenesis
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism
  • Toll-Like Receptor 4 / metabolism*

Substances

  • Lipopolysaccharides
  • Reactive Oxygen Species
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • Nitric Oxide